Juno Therapeutics Probability of Future Stock Price Finishing Over 71.37

Juno Therapeutics' future price is the expected price of Juno Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Juno Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
  
Please specify Juno Therapeutics' target price for which you would like Juno Therapeutics odds to be computed.

Juno Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Juno Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Juno Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Juno Therapeutics is not yet fully synchronised with the market data
Juno Therapeutics has some characteristics of a very speculative penny stock
Juno Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 106.56 M. Net Loss for the year was (353.85 M) with profit before overhead, payroll, taxes, and interest of 111.87 M.
Juno Therapeutics currently holds about 927.53 M in cash with (201.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.18.
Over 81.0% of the company shares are owned by institutional investors

Juno Therapeutics Technical Analysis

Juno Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Juno Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Juno Therapeutics. In general, you should focus on analyzing Juno Stock price patterns and their correlations with different microeconomic environments and drivers.

Juno Therapeutics Predictive Forecast Models

Juno Therapeutics' time-series forecasting models is one of many Juno Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Juno Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Juno Therapeutics

Checking the ongoing alerts about Juno Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Juno Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Juno Therapeutics is not yet fully synchronised with the market data
Juno Therapeutics has some characteristics of a very speculative penny stock
Juno Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 106.56 M. Net Loss for the year was (353.85 M) with profit before overhead, payroll, taxes, and interest of 111.87 M.
Juno Therapeutics currently holds about 927.53 M in cash with (201.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.18.
Over 81.0% of the company shares are owned by institutional investors
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in Juno Stock

If you are still planning to invest in Juno Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Juno Therapeutics' history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk